Literature DB >> 8864899

Anabolic effects of prostaglandins in cultured fetal rat calvariae: structure-activity relations and signal transduction pathway.

F N Woodiel1, P M Fall, L G Raisz.   

Abstract

The structure-activity relations and signal transduction pathways for the anabolic effects of prostaglandins were examined in cultured fetal rat calvariae. In the presence of cortisol prostaglandins of the E and F series (10(-9) to 10(-5) M) produced a dose-related increase in [3H]thymidine incorporation up to 4-fold at 24 h. Prostaglandin E2 (PGE2) was also effective in the absence of cortisol. Butaprost (10(-6) M), a selective EP-2 receptor agonist, produced partial stimulation. Prostaglandin D2, prostacyclin, sulprostone, an EP-1 and EP-3 receptor agonist, and fluprostenol, an FP receptor agonist, were ineffective. Forskolin (10(-4) M) increased [3H]thymidine incorporation 3-fold, while phorbol myristate acetate (PMA) (10(-6) M) produced a 1.8-fold increase. Isobutylmethylxanthine (IBMX) increased [3H]thymidine incorporation in control cultures, in the absence of cortisol, and increased the response to PGE2 in control and cortisol-treated cultures. [3H]proline incorporation into collagen and noncollagen protein was measured in the continuous presence of prostaglandins and cortisol for 72-96 h (continuous model) or when prostaglandins and cortisol were applied for 24 h, followed by culture for 48 h in control medium (on/off model). The effects on collagen were greater than on noncollagen proteins, so that the percent of collagen synthesis increased. The effects of prostaglandins and forskolin paralleled their mitogenic effects. PMA increased only noncollagen protein. Indomethacin did not diminish the anabolic response, while aphidicolin produced only partial inhibition. We conclude that the anabolic effects of prostaglandins on replication and differentiation of osteoblasts are likely to be mediated by an EP-2 receptor that stimulates adenylate cyclase.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8864899     DOI: 10.1002/jbmr.5650110909

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  7 in total

1.  [Diclofenac inhibits proliferation and matrix formation of osteoblast cells].

Authors:  D Kaspar; C M Hedrich; C Schmidt; A Liedert; L E Claes; A A Ignatius
Journal:  Unfallchirurg       Date:  2005-01       Impact factor: 1.000

2.  Short-term supplementation of COX-2 inhibitor suppresses bone turnover in gonad-intact middle-aged male rats.

Authors:  Chwan-Li Shen; James K Yeh; Xingjia Wang
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

3.  An EP2 receptor-selective prostaglandin E2 agonist induces bone healing.

Authors:  V M Paralkar; F Borovecki; H Z Ke; K O Cameron; B Lefker; W A Grasser; T A Owen; M Li; P DaSilva-Jardine; M Zhou; R L Dunn; F Dumont; R Korsmeyer; P Krasney; T A Brown; D Plowchalk; S Vukicevic; D D Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2003-05-14       Impact factor: 11.205

4.  Effect of deletion of the prostaglandin EP2 receptor on the anabolic response to prostaglandin E2 and a selective EP2 receptor agonist.

Authors:  Shilpa Choudhary; Cynthia Alander; Peili Zhan; Qi Gao; Carol Pilbeam; Lawrence Raisz
Journal:  Prostaglandins Other Lipid Mediat       Date:  2008-02-29       Impact factor: 3.072

Review 5.  Cyclooxygenase-2 inhibitors: promise or peril?

Authors:  Laurel J Mengle-Gaw; Benjamin D Schwartz
Journal:  Mediators Inflamm       Date:  2002-10       Impact factor: 4.711

Review 6.  NSAID therapy effects on healing of bone, tendon, and the enthesis.

Authors:  Bailey Su; J Patrick O'Connor
Journal:  J Appl Physiol (1985)       Date:  2013-07-18

Review 7.  Dose-dependent roles of aspirin and other non-steroidal anti-inflammatory drugs in abnormal bone remodeling and skeletal regeneration.

Authors:  Yong Xie; Meng Pan; Yanpan Gao; Licheng Zhang; Wei Ge; Peifu Tang
Journal:  Cell Biosci       Date:  2019-12-23       Impact factor: 7.133

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.